These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18854836)

  • 21. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
    Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
    Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glioblastomas: clinical study and search for prognostic factors].
    Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G
    Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
    Devaux BC; O'Fallon JR; Kelly PJ
    J Neurosurg; 1993 May; 78(5):767-75. PubMed ID: 8468607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic guided laser-induced interstitial thermotherapy (SLITT) in gliomas with intraoperative morphologic monitoring in an open MR: clinical expierence.
    Leonardi MA; Lumenta CB
    Minim Invasive Neurosurg; 2002 Dec; 45(4):201-7. PubMed ID: 12494354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
    Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW
    Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of human malignant glioma cells from histologically normal brain.
    Silbergeld DL; Chicoine MR
    J Neurosurg; 1997 Mar; 86(3):525-31. PubMed ID: 9046311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing incidence and improved survival of gliomas.
    Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
    Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.
    Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A
    J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas.
    Birlik B; Canda S; Ozer E
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):532-8. PubMed ID: 16972887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of diagnostic neuronal markers and outcome in glioblastoma.
    Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
    Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell adoptive immunotherapy of newly diagnosed gliomas.
    Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S
    Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A commentary on the biology and growth kinetics of low-grade and high-grade gliomas.
    Hoshino T
    J Neurosurg; 1984 Nov; 61(5):895-900. PubMed ID: 6491735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of urokinase-type plasminogen activator in human gliomas.
    Hsu DW; Efird JT; Hedley-Whyte ET
    Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferative activity of chosen central nervous system (CNS) neoplasms.
    Lebelt A; Szkudlarek M; Guzińska-Ustymowicz K; Lemancewicz D; Zimnoch L; Dziecioł J
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():242-3. PubMed ID: 15638437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.